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Effect of preoperative versus postoperative
use of transversus abdominis plane block
with plain 0.25 % bupivacaine on
postoperative opioid use: a retrospective
study
Richard Kalu1, Peter Boateng2, Lauren Carrier2, Jaime Garzon2, Amy Tang3, Craig Reickert4 and Amalia Stefanou4*

Abstract
Background: Enhanced recovery protocols optimize pain control via multimodal approaches that include
transversus abdominis plane (TAP) block. The aim of this study was to evaluate the effect of preoperative vs.
postoperative plain 0.25 % bupivacaine TAP block on postoperative opioid use after colorectal surgery.
Methods: A retrospective cohort study comparing postoperative opioid use in patients who received preoperative
(n = 240) vs. postoperative (n = 22) plain 0.25 % bupivacaine TAP blocks. The study was conducted in a single
tertiary care institution and included patients who underwent colorectal resections between August 2018 and
January 2020. The primary outcome of the study was postoperative opioid use. Secondary outcomes included
operative details, length of stay, reoperation, and readmission rates.
Results: Patients who received postoperative plain 0.25 % bupivacaine TAP blocks were less likely to require
postoperative patient-controlled analgesia (PCA) (59.1 % vs. 83.3 %; p = 0.012) and opioid medications on discharge
(6.4 % vs. 16.9 %; p = 0.004) relative to patients who received preoperative TAP. When needed, a significantly smaller
amount of opioid was prescribed to the postoperative group (84.5 vs. 32.0 mg, p = 0.047). No significant differences
were noted in the duration of postoperative PCA use, amount of oral opioid use, and length of stay.
Conclusions: Plain 0.25 % bupivacaine TAP block administered postoperatively was associated with significantly
lower need for postoperative PCA and discharge opioid medications. The overall hospital length of stay was not
affected by the timing of TAP block. Because of the limited sample size in this study, conclusions cannot be
generalized, and more research will be required.
Keywords: Transversus abdominis plane block, Preemptive analgesia, TAP block
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Background
Enhanced recovery protocols (ERP) after surgery have
the aim of reducing morbidity and the surgical stress response while advancing early return of patients to their
baseline functioning [1]. Components of ERP include
optimal pain control and surgical stress reduction with
regional anesthesia, early mobilization, and early enteral
nutrition [2, 3]. Multiple studies including randomized
controlled trials have shown a reduction in hospital
length of stay, duration of postoperative ileus, reduced
morbidity, and an earlier return of normal function after
ERP implementation [1, 4–6].
Optimal pain management is an integral part of an
ERP, particularly after colon surgery. Poor pain control
may lead to longer length of stay, cost, and patient dissatisfaction [6]. Many ERPs use a multimodal approach
to achieve an optimal pain control, employing neuraxial
and regional anesthesia techniques and lower utilization
of opioids as the primary analgesic [7–9]. Transversus
abdominis plane (TAP) block is an example of a regional
anesthetic technique that has been used extensively in
abdominal surgery [10, 11]. The TAP block involves
injecting plain 0.25 % bupivacaine into the fascial plane
between the internal oblique and transversus abdominis
muscles. The duration of action for plain bupivacaine
ranges from 2 to 10 h with peak effect noted around 30
to 45 min {Beiranvand, 2018 #348} [12].
A TAP block may be administered at any time during
the immediate perioperative period. However, whether
plain bupivacaine TAP block is effective in colorectal
surgery remains to be elucidated. There have been no
studies assessing the timing of TAP block administration
for optimal postoperative pain control. In the present
study, we assessed the effect of preoperative vs. postoperative administration of TAP block using plain 0.25 %
bupivacaine on postoperative opioid use in patients
undergoing colorectal surgery. Furthermore, we assessed
for any effects on length of stay, rates of reoperation,
and readmission.

Page 2 of 6

procedure-related details, and postoperative opioid use
after the index operation until discharge. The study was
approved by the Henry Ford Health System Institutional
Review Board. This manuscript was conducted in accordance with the ethical standards laid down in the
amended 1964 Declaration of Helsinki.
Patients were divided in 2 groups based on timing of
TAP block procedure: before (preoperative) or immediately after (postoperative) their surgical procedure.
TAP block technique

Under ultrasound guidance, TAP blocks were performed by,
or under supervision of, the attending anesthesiologist who
specializes in acute pain management and regional
anesthesia. The blocks were performed either 1 h preoperatively or at the conclusion of the surgery procedure within
30 min of reaching the post-anesthesia care unit. The TAP
block consisted of bilateral injection of 20 mL of 0.25 % plain
bupivacaine in the fascial plane between the internal oblique
and transversus abdominis muscles in the midaxillary line.
None of the patients in the 2 groups received additional regional anesthesia, including epidural or spinal anesthesia.
Additional multimodal adjuncts

Our postoperative pain management protocol consisted of
scheduled acetaminophen, muscle relaxant (methocarbamol
or cyclobenzaprine), gabapentin, and ketorolac in the absence of any contraindication. Patient-controlled analgesia
(PCAs) were initiated for patients who had inadequate pain
control, had pain-related hypertension or tachycardia, or
were unable to ambulate or participate in pulmonary toilet.
All patients were routinely assessed for their pain levels.
However, the use of numerical pain scoring was not consistent amongst the patients and hence, was not included in the
study. While there may be minor differences in pain management based on specific surgeon-preference, most of the patients were treated using this protocol. Finally, the decision
to prescribe discharge opioid was based on several factors
such as surgeon’s discretion, the level patient’s pain control,
and history of chronic opioid use.

Methods
Patient selection

Outcomes

All patients who received TAP blocks during a transabdominal colorectal resection between August 2018 and
January 2020 were identified through hospital chart review. The TAP procedure was performed by the regional
anesthesiologist on duty that day. The majority of TAP
blocks are performed preoperatively in our institution.
At times, the TAP block was done at the conclusion of
the operation often due to timing issues. All included
patients underwent colorectal resection done by colon
and rectal surgeons at our tertiary care hospital. We abstracted patient demographics, medical comorbidities,
preoperative diagnosis, past medical and surgical history,

The primary outcome of the study was postoperative
opioid use. The incidence, type, and total amount of opioid in milligram morphine equivalent (MME) and nonopioid analgesic medications administered after the
index procedure were recorded. Secondary outcomes included procedure-related operative details, length of
hospital stay, rates of readmission, and reoperation.
Statistical analysis

Statistical analyses were conducted to compare the baseline
characteristics of the patients who received preoperative
TAP blocks with those who received postoperative TAP
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blocks. Continuous variables were described using the mean
and standard deviation (SD), and categorical variables were
described with the frequency and percentage. Analysis of
variance or Kruskal–Wallis tests were used for continuous
variables and chi-square tests or Fisher’s exact tests were
used for categorical variables as appropriate. P < 0.05 was
considered statistically significant. All analyses were done in
SAS 9.4 (SAS Institute, Cary, NC).

Results
Descriptive analysis

A total of 262 patients were identified through chart review. A total of 240 patients received preoperative TAP
blocks and 22 received postoperative TAP blocks. The
mean (SD) patient age was 57.8 years (16 years), 45 %
were men, and the mean (SD) body mass index was
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28.4 kg/m2 (7.32 kg/m2). There were no significant differences in the 2 groups with regard to age, sex, body
mass index, American Society of Anesthesiology classification, history of cancer or inflammatory bowel disease,
and opioid use at the time of the index procedure
(Table 1). The 2 groups were similar in terms of comorbidities, including history of hypertension, diabetes mellitus, hyperlipidemia, congestive heart failure, chronic
pulmonary obstructive disease, smoking, and alcohol
use. The surgical indications and surgical approaches
were similar between the 2 groups (Table 1).

Analgesic Requirements

Table 2 shows the postoperative analgesics used by the
two groups. The patients who received plain bupivacaine

Table 1 Patient characteristics based on timing of plain transversus abdominis plane (TAP) block
Variables

Overall
(N = 262)

Preoperative TAP
(n = 240)

Postoperative TAP
(n = 22)

P-value

Age, years, mean (SD)

57.76 (16.10)

57.83 (15.87)

56.95 (18.90)

0.807

Male, no. (%)

118 (45.0)

107 (44.6)

11 (50.0)

0.791

Body mass index, kg/m2, mean (SD)

28.38 (7.32)

28.51 (7.48)

27.03 (5.27)

0.366

Diabetes mellitus, no. (%)

67 (25.6)

64 (26.7)

3 (13.6)

0.278

Hyperlipidemia, no. (%)

156 (59.5)

144 (60.0)

12 (54.5)

0.786

Cigarette smoking, no. (%)

85 (32.4)

80 (33.3)

5 (22.7)

0.436

History of COPD, no. (%)

21 (8.0)

19 (7.9)

2 (9.1)

0.692

Alcohol use, no. (%)

126 (48.1)

113 (47.1)

13 (59.1)

0.392

Hypertension, no. (%)

132 (50.4)

121 (50.4)

11 (50.0)

0.99

History of CHF, no. (%)

22 (8.4)

21 (8.8)

1 (4.5)

0.705

Current opioid use, no. (%)

43 (16.5)

41 (17.2)

2 (9.1)

0.499

Steroid use, no. (%)

37 (14.1)

31 (12.9)

6 (27.3)

0.126

Previous abdominal surgery, no. (%)

170 (64.9)

157 (65.4)

13 (59.1)

0.718

Aspirin

52 (19.8)

47 (19.6)

5 (22.7)

0.941

Warfarin

7 (2.7)

6 (2.5)

1 (4.5)

0.463

Plavix

11 (4.2)

11 (4.6)

0 (0.0)

0.607

Others

25 (9.5)

22 (9.2)

3 (13.6)

0.451

Blood thinner use, no. (%)

ASA class, no. (%)

0.241

ASA class 1

1 (0.4)

1 (0.4)

0 (0.0)

ASA class 2

85 (32.4)

78 (32.5)

7 (31.8)

ASA class 3

169 (64.5)

156 (65.0)

13 (59.1)

ASA class 4

7 (2.7)

5 (2.1)

2 (9.1)

ASA > 2

176 (67.2)

161 (67.1)

15 (68.2)

Malignancy

129 (49.2)

119 (49.6)

10 (45.5)

0.882

IBD

52 (19.8)

46 (19.2)

6 (27.3)

0.401

Benign disease

128 (48.9)

116 (48.3)

12 (54.5)

0.738

0.99

Surgical indication, no. (%)

ASA American Society of Anesthesiology, COPD chronic obstructive pulmonary disease, CHF congestive heart failure, IBD inflammatory bowel disease,
SD standard deviation
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Table 2 Postoperative analgesics use based on when the plain TAP block was administered
Variables

Overall
(N = 262)

Preoperative TAP
(n = 240)

Postoperative TAP
(n = 22)

P-value

PCA use, no. (%)

213 (81.3)

200 (83.3)

13 (59.1)

0.012

172 (65.6)

165 (68.8)

7 (31.8)

PCA type
Morphine

0.003

Hydromorphone

31 (11.8)

26 (10.8)

5 (22.7)

Morphine + hydromorphone

10 (3.8)

9 (3.8)

1 (4.5)

27.40 (57.37)

27.09 (51.87)

30.77 (101.32)

PCA amount, MME, mean (SD)
Morphine

0.019

PCA duration, hours, mean (SD)

33.97 (64.30)

34.66 (66.22)

26.36 (37.48)

0.263

IV opioid use, no. (%)

54 (20.6)

46 (19.2)

8 (36.4)

0.102

IV opioid amount, mg, mean (SD)

1.80 (10.39)

1.38 (9.07)

6.42 (19.50)

0.051

Oral opioid amount, MME, mean (SD)

93.94 (153.61)

87.71 (117.82)

161.93 (360.53)

0.743

Discharge opioid, MME, mean (SD)

123.52 (123.01)

128.09 (126.78)

73.64 (48.03)

0.005

Prescription muscle relaxants on discharge, no. (%)

108 (41.4)

97 (40.6)

11 (50.0)

0.528

Opioid use on first postoperative follow-up, no. (%)

19 (7.3)

18 (7.5)

1 (4.5)

0.99

Opioid refill request at first postoperative follow up, no. (%)

3 (1.1)

2 (0.8)

1 (4.5)

0.605

IV intravenous, PCA patient-controlled analgesia, SD standard deviation, TAP transversus abdominis plane, MME morphine milligram equivalent

TAP blocks postoperatively experienced a statistically
significant reduction in the overall use of PCA compared
with those who received preoperative TAP blocks
(59.1 % vs. 83.3 %; p = 0.012). However, when given a
PCA, the postoperative TAP group used a significantly
higher amount of morphine compared to their counterparts (30.77 MME vs. 27.09 MME; p = 0.019). The postoperative TAP group was less likely to be prescribed
opioid medication at the time of discharge (6.4 % vs.
16.9 %; p = 0.004). For patients who received prescription
opioid at the time of discharge, the patients who had
postoperative TAP received a significantly smaller
amount of opioid (128.09 MME vs. 73.64 MME; p =
0.047). There were no differences between the groups
with regard to duration of PCA or intravenous and oral
opioid use.

Procedure-related details, length of stay, reoperation, and
readmission

Table 3 presents the procedure-related details, length of
stay, and reoperation and readmission rates for the 2
groups. Surgical approach did not differ based on timing
of the regional anesthesia. There was no statistically significant difference in procedure length, estimated blood
loss, length of hospital stays, reoperation, or readmission
rates between the 2 groups.

Discussion
Postoperative pain management is an integral part of
achieving the goals of ERPs after colorectal surgery. TAP

blocks are an attractive approach for minimizing the use
of opioids, especially given their low risk of adverse effects. Although usually done preoperatively, our study
showed that postoperative TAP block with plain bupivacaine appeared to be at least as efficacious as preoperative TAP block in reducing postoperative intravenous
opioid use, both PCA and administered intravenous injections. Furthermore, postoperative plain TAP block
was associated with a reduced total amount of prescription opioids needed to the time of discharge from the
hospital. Other variables such as length of stay, estimated operative blood loss, procedure length, reoperation and readmission rates did not differ between
preoperative or postoperative administration of the TAP.
The effectiveness and feasibility of TAP blocks in colorectal surgery has been shown in multiple studies [7,
13–17]. In a randomized, placebo-controlled clinical
trial, Tikuisis et al. showed that patients who received
ropivacaine TAP blocks had significantly lower pain
scores at 2, 4, and 12 h at rest, and at 2- and 4-hours
during movement. The TAP group also used significantly less fentanyl and ketorolac following a handassisted laparoscopic left hemicolectomy for colon cancer compared to those who received placebo [13]. Pirrera et al. compared the use of preoperative ropivacaine
TAP block vs. thoracic epidural analgesia in patients before elective laparoscopic colon resection. Both patient
groups were a part of a standard enhanced recovery after
surgery pathway. Albeit a case-control study, pain control was comparable between the 2 groups. Additionally,
the TAP group had significantly lower rates of postoperative nausea, vomiting, ileus, and paresthesia. There was
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Table 3 Procedure-related details, length of stay, reoperation, and readmission
Variables

Overall
(N = 262)

Preoperative TAP
(n = 240)

Postoperative TAP
(n = 22)

Surgical procedure, no. (%)
a

P-value
0.554

Surg_type1

195 (74.4)

178 (74.2)

17 (77.3)

Surg_type2b

38 (14.5)

36 (15.0)

2 (9.1)

Surg_type3c

11 (4.2)

9 (3.8)

2 (9.1)

Surg_type4d

18 (6.9)

17 (7.1)

1 (4.5)

Open

69 (26.3)

62 (25.8)

7 (31.8)

Laparoscopic

79 (30.2)

75 (31.2)

4 (18.2)

Robotic

114 (43.5)

103 (42.9)

11 (50.0)

2 (0.8)

1 (0.4)

1 (4.5)

0.161

Surgical approach, no. (%)

0.439

Procedure details
Emergent procedure, no. (%)
Procedure length, minutes (SD)

208.38 (96.27)

207.79 (97.16)

214.82 (87.76)

0.655

EBL in mL, mean (SD)

100.05 (185.54)

100.43 (190.96)

95.91 (113.14)

0.855

LOS in days, mean (SD)

4.92 (5.95)

4.82 (5.62)

6.00 (8.87)

0.836

Readmission rate, no. (%)

29 (11.2)

28 (11.8)

1 (4.5)

0.485

Reoperation rate, no. (%)

5 (1.9)

4 (1.7)

1 (4.5)

0.901

EBL estimated blood loss, LOS length of day, SD standard deviation, TAP transversus abdominis plane
a
surg_type1 includes hemicolectomy, sigmoidectomy, low anterior resection, total abdominal colectomy and abdominoperineal resection
b
surg_type2 includes ostomy reversal
c
surg_type3 includes ostomy creation
d
surg_type4 includes appendectomy, exploratory laparotomy, lysis of adhesion, and rectopexy

no significant difference in hospital length of stay or 30day readmission rate. In a prospective, randomized,
double-blind study, Keller et al. assessed the effect of
TAP blocks on postoperative pain in patients following
laparoscopic colorectal resections. Compared to their
counterparts, the TAP group had significantly lower pain
scores and used fewer opioids. However, there was no
difference in hospital length of stay and readmission rate
between the groups [17]. These research study findings
are consistent with our current results.
Considering the short duration of action of plain bupivacaine, the timing of its administration for TAP blocks
can be planned to provide optimal analgesia. Preoperative
administration is easily performed in the preoperative area
and does not affect surgical planning such as ostomy procedures. It is also in line with preemptive analgesia. Oliveira et al., through a meta-analysis that included a variety
of abdominopelvic surgeries, reported a greater postoperative pain control, reduced pain at rest, and decreased opioid used with preoperative TAP compared to placebo or
no treatment [18]. The majority of the TAP blocks performed in our study were performed preoperatively, but
we found more benefit with postoperative TAP blocks.
While the numbers are small in the postoperative TAP
group, the postoperative TAP group did not show inferior
pain control compared to preoperative administrated
block. In fact, our results showed that plain bupivacaine
TAP administered postoperatively led to a reduced

postoperative intravenous opioid use and lesser amount of
discharge prescription opioid.
The study was limited by its retrospective design, the
small number of patients who received postoperative
plain bupivacaine TAP block procedures, and by having
been performed in a single center. Although the TAP
blocks were performed by, or under supervision of, the
attending anesthesiologists who specialize in acute pain
management and regional anesthesia, we acknowledge
the possibility that performer-related differences could
lead to differences in pain relief. However, the regional
block was administered by well-trained and experienced
anesthesiologists who routinely perform the procedure,
hence minimizing the effect of performer-related differences. Finally, our study did not directly measure the patient pain scores. Instead, we used the amount of
postoperative opioid used as a surrogate for the adequacy of pain control. Per our ERP, additional analgesia
is prescribed on an as-needed basis and coincides with
the patient’s assessment of pain on a numeric scale.

Conclusions
TAP blocks provide an effective and feasible means of
optimizing pain control in the era of enhanced recovery
after surgery. When administered postoperatively, plain
bupivacaine TAP may be as effective as preoperative
TAP blocks, offering the same analgesic effect and minimizing intravenous opioid use.
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